Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
AmerisourceBergen Corporation is a medical distribution business based in the US. AmerisourceBergen Corporation shares (ABC) are listed on the NYSE and all prices are listed in US Dollars. AmerisourceBergen Corporation employs 38,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $131.52 |
|---|---|
| 52-week range | $99.61 - $136.95 |
| 50-day moving average | $126.65 |
| 200-day moving average | $121.45 |
| Wall St. target price | $150.92 |
| PE ratio | 17.797 |
| Dividend yield | $1.76 (1.4%) |
| Earnings per share (TTM) | $7.39 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $131.52 from 2022-01-21
| 1 week (2022-01-14) | -3.44% |
|---|---|
| 1 month (2021-12-23) | 1.54% |
| 3 months (2021-10-20) | N/A |
| 6 months (2021-07-23) | 8.42% |
| 1 year (2021-01-22) | 22.05% |
|---|---|
| 2 years (2020-01-24) | 47.91% |
| 3 years (2019-01-24) | 67.12% |
| 5 years (2017-01-24) | 55.81% |
Valuing AmerisourceBergen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AmerisourceBergen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AmerisourceBergen Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, AmerisourceBergen Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AmerisourceBergen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4977. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AmerisourceBergen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
AmerisourceBergen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a AmerisourceBergen Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $214 billion |
|---|---|
| Operating margin TTM | 1.25% |
| Gross profit TTM | $6.8 billion |
| Return on assets TTM | 3.29% |
| Return on equity TTM | 0% |
| Profit margin | 0.72% |
| Book value | $1.07 |
| Market capitalisation | $27.4 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like AmerisourceBergen Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 8.4
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and AmerisourceBergen Corporation's overall score of 8.4 (as at 12/31/2018) is excellent – landing it in it in the 3rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like AmerisourceBergen Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.11/100
Social score: 5.01/100
Governance score: 1.78/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. AmerisourceBergen Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that AmerisourceBergen Corporation hasn't always managed to keep its nose clean.
AmerisourceBergen Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 8.4 |
|---|---|
| Total ESG percentile | 2.5 |
| Environmental score | 1.11 |
| Social score | 5.01 |
| Governance score | 1.78 |
| Level of controversy | 3 |
Dividend payout ratio: 19.22% of net profits
Recently AmerisourceBergen Corporation has paid out, on average, around 19.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AmerisourceBergen Corporation shareholders could enjoy a 1.4% return on their shares, in the form of dividend payments. In AmerisourceBergen Corporation's case, that would currently equate to about $1.76 per share.
While AmerisourceBergen Corporation's payout ratio might seem low, this can signify that AmerisourceBergen Corporation is investing more in its future growth.
AmerisourceBergen Corporation's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 November 2021 (the "ex-dividend date").
AmerisourceBergen Corporation's shares were split on a 2:1 basis on 15 June 2009. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AmerisourceBergen Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for AmerisourceBergen Corporation shares which in turn could have impacted AmerisourceBergen Corporation's share price.
Over the last 12 months, AmerisourceBergen Corporation's shares have ranged in value from as little as $99.6054 up to $136.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while AmerisourceBergen Corporation's is 0.5073. This would suggest that AmerisourceBergen Corporation's shares are less volatile than average (for this exchange).
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. .
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
